abstract |
(a) Formula (I) A compound that is a pyrimidinesulfonamide of (b) or a pharmaceutically acceptable salt thereof, a crystalline form of the compound, a method of obtaining the compound, a pharmaceutical intermediate used in the preparation of the compound, and a pharmaceutical composition comprising the compound Is provided. The compounds are useful in the treatment of diseases / conditions where modulation of chemokine receptor activity is beneficial. |